Mohammad Breakeit1, Daniel Liu2, Adrian Cheng2, Hyerim Suh2, Shoma Barat2, Amer Matar2, Nayef Alzahrani2,3, David L Morris2,4. 1. Department of Surgery, St George Hospital, Sydney, NSW, Australia; Mohammad.Breakeit@health.nsw.gov.au. 2. Department of Surgery, St George Hospital, Sydney, NSW, Australia. 3. Department of Surgery, National Guard Health Affairs, King Abdulaziz Medical City, Riyadh, Kingdom of Saudi Arabia. 4. University of New South Wales, Sydney, NSW, Australia.
Abstract
BACKGROUND/AIM: Up to a third of patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis (PC) of appendiceal or colorectal origin receive a stoma during primary surgery. Stoma reversal provides an opportunity for second-look surgery. PATIENTS AND METHODS: We performed a retrospective analysis of prospectively collected data of patients with colorectal cancer (CRC) or high-grade appendiceal cancer (AC) from 2006 to 2021 from our database. A total of 34 consecutive stoma closure patients with no evidence of preoperative disease recurrence (tumor markers and CT scans) were compared with 141 consecutive re-do CRS/HIPEC patients with known recurrence. RESULTS: Eleven patients (32.4%) were identified to have peritoneal recurrence at stoma closure. Time between first and second CRS was 12 months (4 to 64.2) in the stoma closure group vs. 24.6 months (5.8 to 119.8) in the re-do group, while median peritoneal cancer index (PCI) was 4 (3 to 6) vs. 8 (1 to 39), respectively (p=0.0143). CONCLUSION: Second-look laparotomy during stoma closure identified unexpected PC in 32.4% of our patients with significantly lower PCI than planned re-do operations.
BACKGROUND/AIM: Up to a third of patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis (PC) of appendiceal or colorectal origin receive a stoma during primary surgery. Stoma reversal provides an opportunity for second-look surgery. PATIENTS AND METHODS: We performed a retrospective analysis of prospectively collected data of patients with colorectal cancer (CRC) or high-grade appendiceal cancer (AC) from 2006 to 2021 from our database. A total of 34 consecutive stoma closure patients with no evidence of preoperative disease recurrence (tumor markers and CT scans) were compared with 141 consecutive re-do CRS/HIPEC patients with known recurrence. RESULTS: Eleven patients (32.4%) were identified to have peritoneal recurrence at stoma closure. Time between first and second CRS was 12 months (4 to 64.2) in the stoma closure group vs. 24.6 months (5.8 to 119.8) in the re-do group, while median peritoneal cancer index (PCI) was 4 (3 to 6) vs. 8 (1 to 39), respectively (p=0.0143). CONCLUSION: Second-look laparotomy during stoma closure identified unexpected PC in 32.4% of our patients with significantly lower PCI than planned re-do operations.
Authors: Konstantinos Ioannis Votanopoulos; David Bartlett; Brendan Moran; Choudry M Haroon; Greg Russell; James F Pingpank; Lekshmi Ramalingam; Chandrakumaran Kandiah; Konstantinos Chouliaras; Perry Shen; Edward A Levine Journal: Ann Surg Oncol Date: 2017-12-29 Impact factor: 5.344
Authors: Cristian D Valenzuela; Edward A Levine; Christopher W Mangieri; Rohin Gawdi; Omeed Moaven; Gregory Russell; Megan E Lundy; Kathleen C Perry; Konstantinos I Votanopoulos; Perry Shen Journal: Ann Surg Oncol Date: 2022-03-14 Impact factor: 4.339
Authors: Vic J Verwaal; Serge van Ruth; Eeclo de Bree; Gooike W van Sloothen; Harm van Tinteren; Henk Boot; Frans A N Zoetmulder Journal: J Clin Oncol Date: 2003-10-15 Impact factor: 44.544
Authors: Eelco de Bree; Wim Koops; Robert Kröger; Serge van Ruth; Arjen J Witkamp; Frans A N Zoetmulder Journal: J Surg Oncol Date: 2004-05-01 Impact factor: 3.454
Authors: Heather L Van Sweringen; Dennis J Hanseman; Syed A Ahmad; Michael J Edwards; Jeffrey J Sussman Journal: Surgery Date: 2012-09-01 Impact factor: 3.982